• Skip to main content
  • Skip to primary sidebar

An Inconvenient Truth: This Is a Woman

Don’t Get Angry, Get Active!

Hide Search

Statistic Breakdown of Indiana University School of Medicine Primary HPV Study

H. Sandra Chevalier-Batik · March 15, 2006 ·

Study reveals high infection rate in teens for virus linked to cervical cancer

Based on 60 study participants from three primary-care clinics in Indianapolis HPV rates reported in previous research have been underestimated. The latest study indicates four out of five sexually active adolescent females are infected with the human papillomavirus (HPV).

Human papillomavirus is a common sexually transmitted infection, and its effects may range from no symptoms to genital warts to cervical cancer.

Researchers have concluded that the high HPV infection rate in sexually active adolescent females for is linked to the onset of to cervical cancer in later life.

Statistical break down of the 60 Study Participants

Age of Study participants — 14 to 17

95% of the participants were sexually active

Median number of sexual partners — 2

85% were African American

11% were Caucasian

3% were Hispanic.

Study Methodology

Quarterly visits to a primary-care clinic for a cervical swab test 5 three-month diary collection periods (self recorded daily sexual activity) Self-performed, weekly vaginal swabbing

Average Participation in study — 2-years

Total swab specimens collected and analyzed for HPV infection — 2,100

49 of 60 study participants tested positive for HPV infection (82% prevalence rate)

HPV-positive study participants were infected with not just one, but also multiple, HPV types.

Mean number of HPV types per participant — 5

Number of those HPV types associated with an increased risk for cervical cancer:

39 % of the swab specimens were classified as high-risk types

20 % as low-risk

37% of study participants had at least one abnormal result for cervical examination during the study period.

“Brown and colleagues hypothesized that relative to earlier research, the high cumulative prevalence of HPV infection in their study was primarily a result of the high number of swab specimens obtained from each study participant. Many infections were detectable for only a few weeks and might have been missed had specimens been obtained at longer intervals of time.

They also attributed the high prevalence to their use of a test that detects more HPV types than some other tests do, and to the at-risk nature of this particular study population.” (2)

Sources:

(1) Jan. 15 issue of the Journal of Infectious Diseases

Research report, Dr. Darron Brown and colleagues at the IU School of Medicine

(2) Indiana University

IU Home Pages

400 E. 7th Street. Bloomington, IN 47405

Phone: (812) 855-6494

Publication Date: March 11, 2005

Comments: homepgs@indiana.edu

Share

Filed Under: Cervical Cancer, FDA Clinical Trials, HPV Infection, STD Infection Tagged With: Cervical Cancer, FDA Clinical Trials, HPV Infection, STD Infection

Primary Sidebar

Categories

  • Attention-Deficit/Hyperactivity Disorder Medications
  • Big Pharma Watch
  • Biotech Industry
  • Birth Control
  • Breast Cancer
  • cáncer de cuello uterino
  • Cancer Research
  • Cervarix
  • Cervical Cancer
  • Clinical Trials
  • Diabetes
  • Domestic Violence
  • Drug Approvals
  • Emotional Health
  • FDA
  • FDA Black Box Warning
  • FDA Clinical Trials
  • FDA Failure To Protect
  • FDA Product Recall
  • Follow The Money
  • Gardasil
  • Gardasil®
  • Gender Bias
  • Gender Politics
  • genital warts
  • Guillain-Barre Syndrome
  • Hormone Cycle
  • HPV Infection
  • HPV Vaccine
  • HRT
  • HRT Side Effects
  • Influenza A Virus H1N1 Strain
  • Mammograms
  • Mandatory HPV Vaccination Policies
  • Medical Technology
  • Menopause
  • MERCK Watch
  • MMR vaccine
  • National Vaccine Injury Compensation Program
  • PAP Test
  • Prescription Drug Side Effects
  • Proactive Nutrition
  • Product Recall
  • Reproductive Health
  • Sexual Dysfunction
  • Sleep Loss
  • STD Infection
  • Stroke
  • Take Action!
  • Uncategorized
  • Unwanted Pregnancy
  • Vaccination Policy
  • VAERS
  • vaginal yeast infection
  • Virginity
  • Weight Gain
  • Women's Health
  • Women's Rights
  • Work Place Issues
  • World Health Organization
  • Yeast Infection
  • Your Body/Your Self

Archives

  • February 2010
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • March 2006
  • September 2005
  • June 2005
  • May 2005
  • December 2004
April 2025
S M T W T F S
 12345
6789101112
13141516171819
20212223242526
27282930  
« Feb    

Breast Cancer

  • Cancer Advocacy

Health Advocacy

  • Women’s Universal Health Initiative

Syndication

  • FDA MedWatch

Tags

Big Pharma Watch Birth Control Breast Cancer Cancer Cancer Research CDC Cervarix Cervical Cancer Children's Health Exploitive Behavior FDA FDA Approvals FDA Clinical Trials FDA Failure To Protect FDA Press Release Follow The Money Gardasil Gardasil Adverse Event Gardasil® GlaxoSmithKline GlaxoSmithKline Cervarix Gynecology H1N1 "swine flu" virus H1N1 pandemic influenza preparedness efforts Health Advisory HPV HPV-Associated Cervical Cancer HPV-Vaccination HPV Infection HPV Vaccine HRT Human Papillomavirus (HPV) Infection Merck PAP SMEAR PAP Test Proactive Nutrition Questionable Medicine STD Infection STD Vaccination swine flu vaccine Swine flu vaccine production Take Action! Uncategorized Woman’s Health Your Body/Your Self

Copyright © 2010-2025 Hands On WordPress · All Rights Reserved